Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CSCO 21.30 down over 20% last few days...should be good for easy 5% gain imo
DRV 6.10 down 30% this week, good buy opp imo
YRCW wow running
ARRY a bio well funded with a big pipeling- recent upgrade with a $10 target
ARRY with 467mil in cash + royalties
ARRY alert -Array in $467M cancer drug deal with Novartis
Array licenses cancer drug candidate to Novartis in deal worth up to $467M, plus royalties
On Tuesday April 20, 2010, 11:09 am EDT
NEW YORK (AP) -- Shares of Array BioPharma Inc. surged Tuesday after the company said it licensed a group of experimental cancer treatments to Swiss drugmaker Novartis AG in a deal that could include $467 million in payments plus royalties.
Array licensed its cancer drug candidate ARRY-162, along with similar drugs, to Novartis for $45 million upfront and potential development and regulatory milestone payments of $422 million. The drugs are designed to block an enzyme that is involved in the growth and survival of cancer cells.
Array, which is based in Boulder, Colo., will also get royalty payments of more than 10 percent on sales outside the U.S., and can get larger payments on U.S. sales if it meets funding obligations.
In morning trading Array stock jumped $1.05, or 34.8 percent, to $4.07.
The company is conducting an early-stage trial of ARRY-162 to evaluate the drug's safety and determine the most effective dose. It is being given by mouth to patients with solid tumors, and Array wants to expand the study to include patients with cancer of the biliary tract.
The other drugs involved in the collaboration are ARRY-300, which Array described as a backup to ARRY-162, and other drugs that are intended to block the same enzyme
ARRY $10 target after news yest
http://www.reuters.com/article/idCNSGE63J0LW20100420?rpc=44
ARRY
ARRY 4.11 news play trying to add more
ARRY exploding - buy the dips
PALM 4.99-5.00 alert, buyout in the works
PALM buyout coming- they already hired GS
PALM blowing up :)
PALM alert buyout play...
ARRY $4 up 32% going to explode higher
ARRY 3.99-4.00 very strong on news
PALM absolute gift, company already hired GS to complete the buyout process
PALM- possible buyout $10-14; in lets see how it goes
in PALM and ARRY today
PALM bouncing finally - way oversold
PALM coming off bottome down huge
PALM way over-sold watch for a bounce
PALM crashing
PALM 4.87 turning down 14%
PALM murdered 4.81 down 14%
ABK huge dip :(
ABK wtf ...
ABK broke up $2
ABK 1.94 major alert
SIRI .99 break of $1 and this blows
SIRI explosive - huge buys
SIRI SIRI major alert -98
SIRI alert 117mil in vol already
SIRI dip .97 good luck
ABIO 5.17 dip alert HOD 5.53
ABIO waiting for partnership news- has dropped from 9+
ABIO 5.17 HOD 5.53 huge dip here
ABIO dip- ready for the next leg
ABIO gana explode